« Interesting Finds: Pharma-related posts 8 | Main | Immediate Treatment of Betaseron® Significantly Delayed Permanent Disability in Early MS Patients »

May 3
GSK’s Lamictal® XR™, Found Effective in Treatment of Partial Seizures

GlaxoSmithKline (NYSE: GSK)’s investigational once daily extended release formulation of Lamictal® (lamotrigine) - Lamictal® XR™ - has been found effective as add-on treatment in patients with partial epilepsy with and without secondary generalization.

Currently, Lamictal® XR™ is being developed for the treatment of epilepsy and once approved will become the first extended release, new generation epilepsy treatment taken once-daily.

lamictal200-packshot.jpgThe finding abovementioned was derived from data of two clinical trials recently presented at the American Academy of Neurology (AAN) meeting.

According to Dean Naritoku, M.D., Professor of Neurology and Pharmacology, Southern Illinois University, Springfield, IL.:

"These data are important because they show that the extended release formulation of Lamictal reduces the frequency of seizures. The once daily dosing regimen may also provide a more convenient treatment option for patients.
In addition, when compared to Lamictal immediate release, given twice a day, the new investigational formulation demonstrated fewer daily fluctuations in serum concentration and more stable blood levels over time."

Being suffered by more than three million Americans of all ages (according to the Epilepsy Foundation), epilepsy is defined by recurrent unprovoked seizures and is a change in sensation, awareness, or behavior brought about by an electrical disturbance in the brain.

Read the full report.


1 Comments/Trackbacks




My name is Denise Simon and i would like to show you my personal experience with Lamictal.

I am 57 years old. Have been on Lamictal for 24 weeks now. Lamictal has worked well with no side effects other than the sleep problesm. My problems with other meds included constipation and depression. Lamictal also relieves my anger bouts...and settles me down which probably helps with seizure control.

I have experienced some of these side effects-
Following conversion from tegretol and Zonegran, I began on 400 mg Lamictal. Bad dreams followed with sleep talking and thrashing during dreams. This turned into more vivid short dreams in which I could not discern dreams from reality. I have contacted my Dr asking permission to take the meds earlier and he concurred to try them 4 hrs earlier. HE is leaning toward changing the meds. After laying out a lot of $ for a 3 month supply, I am reluctant to change meds as I am tight on $....

I hope this information will be useful to others,
Denise Simon

submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« Interesting Finds: Pharma-related posts 8 | Main | Immediate Treatment of Betaseron® Significantly Delayed Permanent Disability in Early MS Patients »

Advertise

Watch the Digital Health Revolution


Related Resources

recent comments

    sponsored ads



    subscribe


    Prefer Email?
    Subscribe below-

    Enter your Email:


    Powered by FeedBlitz What's this?

    Current News

    Support This Blog

    blogroll


    top blogs

    business social media

    Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

    BIZZlogos - Add your logo - free link to your site
    BIZZphotos - Add photos of your products and people
    BIZZprofiles - Submit your profile and build your online visibility
    BIZZspotlight - Spotlight your business with free links
    BIZZvideos - Videos about businesses, products and business people.
    BIZZbites - "Digg" for Business - Submit your articles and posts

    Know More Media - Health Care / Pharmaceutical / Fitness

    know more media network

    View Network Map

    Network Feed List (OPML)

    Know More Media Network
    Feed


    we support unitus

    PRWeb

    Influencer



    PharmaGazette is a member of the Know More Media network of business related blogs.

    Here are some current headlines from some of our business publications:

    ProductivityGoal

    CallCenterScript

    AdHurl

    TheBizofKnowledge

    LandingTheDeal

    CustomersAreAlways

    HealthCareVox

    BrainBasedBusiness

    TheInsurancePolicy

    MarketingBlurb